![](/img/cover-not-exists.png)
[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12â15 June 2019 - ()] SATURDAY, 15 JUNE 2019 - SAT0125â LONG-TERM SAFETY WITH SARILUMAB PLUS CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS AND SARILUMAB MONOTHERAPY IN RHEUMATOID ARTHRITIS: AN INTEGRATED ANALYSIS WITH 9,000 PATIENT-YEARS OF FOLLOW-UP
Fleischmann, Roy, Lin, Yong, John, Gregory St, Heijde, Désirée van der, Qiu, Chunfu, Gomez-Reino, Juan Jose, Maldonado-Cocco, Jose Antonio, Stanislav, Marina, Seriolo, Bruno, Burmester, Gerd RüdigeYear:
2019
DOI:
10.1136/annrheumdis-2019-eular.245
File:
PDF, 522 KB
2019